Business Context and Reporting Period
This Form 8-K Current Report is filed by Viking Therapeutics, Inc. (VKTX) on April 23, 2025, regarding events occurring on April 18, 2025. The filing addresses a change in the company's independent registered public accounting firm.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and audit firm transitions rather than financial performance data.
Material Changes
- Resignation of Prior Auditor: Marcum LLP resigned as the independent registered public accounting firm on April 18, 2025. This resignation resulted from the acquisition of Marcum's attest business by CBIZ CPAs P.C. on November 1, 2024.
- Appointment of New Auditor: The Audit Committee approved the appointment of CBIZ CPAs P.C. as the new independent registered public accounting firm on April 22, 2025, effective for the fiscal year ending December 31, 2025.
- Audit History: Marcum's reports for the years ended December 31, 2024, and 2023, were unqualified and contained no adverse opinions, disclaimers, or modifications regarding uncertainty, scope, or accounting principles.
- Disagreements: There were no disagreements or reportable events between the Company and Marcum during the fiscal years 2023 and 2024 or the interim period through April 18, 2025.
Guidance, Outlook, and Management Commentary
The filing does not contain financial guidance, market outlook, or management commentary on business strategy. Management noted that a revised proxy statement will be filed to update the 2025 annual meeting materials (scheduled for May 20, 2025) to reflect the change in the independent registered public accounting firm in Proposal No. 2.
Investor Verification Checklist
- Verify the transition timeline between Marcum LLP and CBIZ CPAs P.C. to ensure no gap in audit coverage.
- Confirm the content of the revised proxy statement for the May 20, 2025, annual meeting to ensure the auditor ratification proposal reflects CBIZ.
- Review the attached letter from Marcum LLP (Exhibit 16.1) to confirm their agreement with the Company's disclosures regarding the resignation.
- Monitor future filings for the first financial statements audited by CBIZ for the fiscal year ending December 31, 2025.